Enliven Therapeutics
ELVN
#3795
Rank
HK$28.43 B
Marketcap
HK$398.07
Share price
-0.20%
Change (1 day)
152.86%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$90.1 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are HK$90.1 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$0.12 B4.33%
2024-12-31HK$0.12 B-39.06%
2023-12-31HK$0.20 B-83.79%
2022-12-31HK$1.25 B2.71%
2021-12-31HK$1.21 B3.85%
2020-12-31HK$1.17 B